Lin Hong
Jiangsu Province Blood Centre, Nanjing 210042, China.
J Trop Med. 2021 Jul 8;2021:3970370. doi: 10.1155/2021/3970370. eCollection 2021.
Although China is moving toward the eradication of malaria and no indigenous malaria has been reported in most Chinese provinces for several years, recent evaluations have revealed that imported cases remain a major challenge to eliminating malaria, with the number of transfusion-transmitted malaria (TTM) cases increasing over time. Here, we review several TTM case reports published after the implementation of the National Malaria Elimination Program in 2010. A total of 12 TTM cases were reported in China between 2013 and 2018. All recipients and donors were diagnosed using rapid diagnosis test and peripheral blood smears. species in donors with low-density parasites were identified using PCR. Nine (75.0%) were identified as , two (16.7%) were identified as , and one (8.3%) was identified as . All were imported from malaria-endemic areas. New action plans designed to meet the challenges of TTM are necessary to ensure the elimination of malaria in China. Paying more attention to the frequency of TTM could help to enhance blood safety in China.
尽管中国正朝着消除疟疾的目标迈进,且多数省份已有数年未报告本土疟疾病例,但最近的评估显示,输入性病例仍是消除疟疾的一项重大挑战,经输血传播的疟疾病例数量也在逐年增加。在此,我们回顾了2010年国家消除疟疾计划实施后发表的几例经输血传播的疟疾病例报告。2013年至2018年间,中国共报告了12例经输血传播的疟疾病例。所有受血者和供血者均通过快速诊断检测和外周血涂片进行诊断。对寄生虫密度较低的供血者的疟原虫种类采用聚合酶链反应进行鉴定。其中9例(75.0%)被鉴定为间日疟原虫,2例(16.7%)为卵形疟原虫,1例(8.3%)为三日疟原虫。所有病例均从疟疾流行地区输入。为应对经输血传播的疟疾带来的挑战,制定新的行动计划对于确保中国消除疟疾至关重要。更加关注经输血传播的疟疾的发生频率,有助于提高中国的血液安全。